Profil
Gordon E.
Nye is currently Chief Executive Officer at R2 Dermatology, Inc. and Managing Director at Group Outcome LLC.
Former roles include President, Chief Executive Officer & Director at ZELTIQ Aesthetics, Inc. from 2009 to 2012; Chief Executive Officer at Avertix Medical, Inc. from 2020 to 2021; Chief Executive Officer at Critikon Co. LLC in 2003; Chief Executive Officer & Director at Clear Intradermal Technologies, Inc.; Chief Executive Officer at A Co. Orthodontics, Inc. in 2003; Director at ROX Medical, Inc., CoAxia, Inc., Myocor, Inc., IScience Surgical Corp., Aptus Endosystems, Inc., Confirma, Inc., and Systagenix Wound Management Ltd.; Director at Insulet Corp.
in 2008; Independent Non-Executive Director at REVA Medical, Inc. from 1999 to 2017; Principal at Prism Venture Management LLC from 2003 to 2009.
Education includes undergraduate and MBAistration degrees from Tuck School of Business at Dartmouth.
Postes actifs de Gordon E. Nye
| Sociétés | Poste | Début |
|---|---|---|
Group Outcome LLC
Group Outcome LLC Investment Banks/BrokersFinance Provides merchant banking services | Corporate Officer/Principal | 30/12/2010 |
R2 Dermatology, Inc.
R2 Dermatology, Inc. Part of Lancer Venture Capital, R2 Dermatology, Inc. is a company based in New York, NY. The CEO of the company is Gordon E. Nye. | Directeur Général | - |
Anciens postes connus de Gordon E. Nye
| Sociétés | Poste | Fin |
|---|---|---|
Avertix Medical Systems, Inc.
Avertix Medical Systems, Inc. Medical SpecialtiesHealth Technology Develops, manufactures and markets cardiac medical devices | Directeur Général | 22/06/2021 |
| REVA MEDICAL INC | Directeur/Membre du Conseil | 14/07/2017 |
| ZELTIQ AESTHETICS INC | Directeur Général | 18/04/2012 |
Prism Venture Management LLC
Prism Venture Management LLC Investment ManagersFinance Prism Venture Management invests in companies located in the United States. The firm targets companies operating in the fields of technology life sciences, digital media and software/services. It provides financing for seed and early stage capital requirements. | Private Equity Investor | 31/12/2009 |
| INSULET CORPORATION | Directeur/Membre du Conseil | 01/01/2008 |
Formation de Gordon E. Nye
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 18 |
|---|---|
ROX Medical, Inc.
ROX Medical, Inc. Medical SpecialtiesHealth Technology Manufactures medical ultrasonic scanning devices | Health Technology |
CoAxia, Inc.
CoAxia, Inc. Medical/Nursing ServicesHealth Services Develops & markets technologies to reduce neurologic damage | Health Services |
Myocor, Inc.
Myocor, Inc. Medical SpecialtiesHealth Technology Develops products for the treatment of mitral regurgitation and congestive heart failure | Health Technology |
IScience Surgical Corp. | Health Services |
Aptus Endosystems, Inc.
Aptus Endosystems, Inc. Medical SpecialtiesHealth Technology Develops and manufactures medical devices | Health Technology |
ZELTIQ Aesthetics, Inc.
ZELTIQ Aesthetics, Inc. Medical SpecialtiesHealth Technology Operates as a medical device company that develops non-invasive procedures for the reduction of unwanted fat tissue | Health Technology |
Prism Venture Management LLC
Prism Venture Management LLC Investment ManagersFinance Prism Venture Management invests in companies located in the United States. The firm targets companies operating in the fields of technology life sciences, digital media and software/services. It provides financing for seed and early stage capital requirements. | Finance |
Critikon Co. LLC
Critikon Co. LLC Medical SpecialtiesHealth Technology Provides blood pressure monitoring products and software for patient information systems | Health Technology |
Insulet Corp.
Insulet Corp. Medical SpecialtiesHealth Technology Manufactures, develops and markets insulin infusion systems | Health Technology |
REVA Medical, Inc.
REVA Medical, Inc. Medical SpecialtiesHealth Technology Develops, manufactures and sells implantable bio resorbable medical devices | Health Technology |
Confirma, Inc.
Confirma, Inc. Packaged SoftwareTechnology Services Develops and markets computer aided detection software | Technology Services |
Group Outcome LLC
Group Outcome LLC Investment Banks/BrokersFinance Provides merchant banking services | Finance |
Avertix Medical Systems, Inc.
Avertix Medical Systems, Inc. Medical SpecialtiesHealth Technology Develops, manufactures and markets cardiac medical devices | Health Technology |
Systagenix Wound Management Ltd.
Systagenix Wound Management Ltd. Medical SpecialtiesHealth Technology Develops wound care products | Health Technology |
A Co. Orthodontics, Inc. | |
Tuck School of Business at Dartmouth
Tuck School of Business at Dartmouth Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
R2 Dermatology, Inc.
R2 Dermatology, Inc. Part of Lancer Venture Capital, R2 Dermatology, Inc. is a company based in New York, NY. The CEO of the company is Gordon E. Nye. | |
Clear Intradermal Technologies, Inc.
Clear Intradermal Technologies, Inc. Medical SpecialtiesHealth Technology Develops tattoo removal devices | Health Technology |
















